Skip to main content
Figure 2 | Malaria Journal

Figure 2

From: The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea

Figure 2

Phenotype prediction from CYP2D6 allelic variants detected by the xTAG™ CYP2D6 Kit v3 (Luminex® Corp., USA). Green corresponds to extensive metabolizer (EM), yellow to intermediate metabolizer (IM), and red to poor metabolizer phenotypes. Our patient’s genotype placement at *5/*41 is shown as blue in an intermediate metabolizer phenotype.

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us